Evidence map›Paper›PMID 32882864›Full record

ArticlePharmaceutics2020

Assessment of CafA Targeted BAR-Encapsulated Nanoparticles against Oral Biofilms.

Hetal Desai, Mohamed Y Mahmoud, Jinlian Tan, Farnaz Minooei, Donald R Demuth, Jill M Steinbach-Rankins

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Hetal DesaiDepartment of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY 40202, USA.
Mohamed Y MahmoudDepartment of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Jinlian TanDepartment of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY 40202, USA.
Farnaz MinooeiCenter for Predictive Medicine, University of Louisville, Louisville, KY 40202, USA.
Donald R DemuthDepartment of Oral Immunology and Infectious Diseases, University of Louisville School of Dentistry, Louisville, KY 40202, USA.
Jill M Steinbach-RankinsDepartment of Microbiology and Immunology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
University of Louisville · USCairo University · EG

Funding

Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative IntravaginalP20GM125504 · NIGMS · UNIVERSITY OF LOUISVILLE · PI Shirin Ghods · 2018 to 2026
$24.4M
Structure-based design and synthesis of peptidominetics targeting P. gingivalisR01DE023206 · NIDCR · UNIVERSITY OF LOUISVILLE · PI DEMUTH, DONALD R, LUZZIO, FREDERICK ANTHONY · 2013 to 2017
$1.9M
Nanoparticle delivery vehicles targeting P. gingivalisR21DE025345 · NIDCR · UNIVERSITY OF LOUISVILLE · PI DEMUTH, DONALD R, STEINBACH-RANKINS, JILL · 2016 to 2017
$424k
NIDCR NIH HHS R01DE023206NIDCR NIH HHS R21DE025345NIGMS NIH HHS P20 GM125504NIGMS NIH HHS P20GM125504
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CafA proteinnanoparticlesoral biofilmoral deliverypeptide deliveryperiodontal diseasePorphyromonas gingivalisStreptococcus gordoniitargeted oral therapy

Identifiers

PMID32882864
PMCPMC7557775
OpenAlexW3082551140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.